HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026
American Journal of Cancer Research · 2026 · 16 (7) · 3193-3197
DOI: 10.62347/yexz3177 ↗Kurz gefasst
Korrektur in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Meng Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University Chongqing, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University Chongqing, China.
Zitieren
APA
Jia, M., Zhou, K. Y., Deng, L. J., & Fang, S. (2026). HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026. American Journal of Cancer Research, 16(7), 3193-3197. https://doi.org/10.62347/yexz3177
Vancouver
Jia M, Zhou KY, Deng LJ, Fang S. HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026. American Journal of Cancer Research. 2026;16(7):3193-3197. doi:10.62347/yexz3177
BibTeX
@article{Jia2026,
author = {Jia, Meng and Zhou, Kai-Yi and Deng, Li-Jia and Fang, Sheng},
title = {HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway: Am J Cancer Res. 2023; 13(7): 3013-3026},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {7},
pages = {3193--3197},
doi = {10.62347/yexz3177}
}
EUVIMED